Guide to U.S. Import Requirements for Cosmetics and Other Personal Care Products - An FDLI Primer by Kathleen Cannon (Co-Editor-In Chief) and Sarah Roller (Co-Editor in Chief) Contributors: Kathleen Cannon, Grace W. Kim, Jennifer L. McDowell, Bridget M. Richardson
Food Law and Regulation, Inspection and Enforcement – an FDLI Primer by Marc C. Sanchez
The Regulation of Medical Devices in Canada by Sara Zborovski, Partner, Davis LLP Andy Radhakant, Partner, Davis LLP Andrew Lord, Associate, Davis LLP
Bringing Your Pharmaceutical Drug to Market by Ralph Hall, Matt Hill, Neil Di Spirito
Food and Drug Law and Regulation, 3rd Edition by David G. Adams, Richard M. Cooper, Martin J. Hahn & Jonathan S. Kahan, Editors
Off-Label Communications: A Guide to Sales & Marketing Compliance, 4th Edition by Edited by Mark Carlisle Levy
Speaker Programs and Practices by FDLI
Enforcement, Litigation, and Compliance by FDLI
Combination Products Workshop – A Comprehensive Overview by FDLI
Introduction to Food Law and Regulation : Understanding How the Government Regulates the Food Industry – PowerPoint presentation with live audio by FDLI
An Exploration of Ethical Issues Raised by Stevens, Stryker Biotech and Similar Cases Audio by
2012 Annual Conference: Address from the Office of Chief Counsel, Former FDA Chief Counsels Roundtable Audio by
Letter from the Editor
by Judy Rein................................................................................................
What’s in a Name? Quantifying the Economic Value of Label Information
by Anthony J. Anscombe.......................
Table of Contents
In “The Story and the Rest of the Story,” issue #10 of the Food and Drug Policy Forum’s 2015 edition, Peter Pitts and R...
FDLI’s Food and Drug Policy Forum #9 (2015), “What Does the Future Hold for Patient-Focused Drug Development?&...
Food and Drug Policy Forum Volume 5, issue 8, 2015, September, 2015.
How regulatory updates allowing for more modern test methods, prag...
Vaccines represent one of the greatest achievements of medicine, dramatically reducing the incidence of serious or life-threatening infec...
The regulation of stem cell-based therapies is challenging in many respects, given their unique safety, efficacy and quality issues. At t...
The widespread availability of drugs for personalized medicine has been an aspiration since before the human genome was sequenced. Recent...
Viewpoints on FDA: Enforcementis an invaluable resource for attorneys, manufacturers, consultants and other food and drug stakeholders, w...
A tough question - but one that FDA, pharmaceutical manufacturers, physicians, patients and the courts now are urgently trying to answer....
Second in a series of discussion on should terminally ill patients get access
to unapproved drugs?
Full Transcript from ...
The authors make the case against regulatory efforts to rein in drug prices.
Let FDLI train your staff with introductory courses. You select the topic and FDLI provides the training.
The law student writing competition is open for submissions. Prizes total $10,000.